Share Name Share Symbol Market Type Share ISIN Share Description
Totally Plc LSE:TLY London Ordinary Share GB00BYM1JJ00 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.375 -2.94% 12.375 319,267 15:34:53
Bid Price Offer Price High Price Low Price Open Price
12.25 12.50 12.75 12.375 12.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 78.01 -1.82 -2.51 23
Last Trade Time Trade Type Trade Size Trade Price Currency
16:37:41 O 25,000 12.25 GBX

Totally (TLY) Latest News

More Totally News
Totally Takeover Rumours

Totally (TLY) Share Charts

1 Year Totally Chart

1 Year Totally Chart

1 Month Totally Chart

1 Month Totally Chart

Intraday Totally Chart

Intraday Totally Chart

Totally (TLY) Discussions and Chat

Totally Forums and Chat

Date Time Title Posts
16/10/201922:49Totally Health - 2014 onwards10,788
11/10/201911:49Feeling Better?535
30/9/201910:13Totally plc - right of reply10
23/7/201920:21Totally plc 20133,525
04/1/201913:45Bob Holt OBE, Chairman – Totally (TLY)4

Add a New Thread

Totally (TLY) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:37:4212.2525,0003,062.50O
14:40:5312.3632,3073,993.95O
14:34:4712.2550,0006,125.00O
14:21:0112.28833102.27O
14:08:1712.368,2331,017.76O
View all Totally trades in real-time

Totally (TLY) Top Chat Posts

DateSubject
16/10/2019
09:20
Totally Daily Update: Totally Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TLY. The last closing price for Totally was 12.75p.
Totally Plc has a 4 week average price of 8.85p and a 12 week average price of 8.70p.
The 1 year high share price is 21.50p while the 1 year low share price is currently 8.70p.
There are currently 182,186,111 shares in issue and the average daily traded volume is 1,253,489 shares. The market capitalisation of Totally Plc is £22,545,531.24.
04/10/2019
16:18
sikhthetech: Bob bought 274 shares... there's a huge difference between that and the small trades, some around 10k/20k at current prices, which are by the gang manipulating the share price, so to use the TLY share price as 'evidence' not to believe my warnings on trmr... Have a look at the trmr/rthm threads on Lse and advfn... 1gw loves to mention TLY when he's caught out and to distract away from his disasters... Like on Byot today... ;-)
20/9/2019
07:59
buywell3: TLY share price halved from Sept 1st 2016 to 15th Nov 2017 TLY share price halved again from sept 20th 2017 to 20th sept 2018 TLY share price halved again from sept 20th 2018 to 20th sept 2019 Seems like a pattern to me
07/8/2019
16:24
grahamwales: Microscope Been here around 3 years now and all I have seen is the share price go down. All I want is for the share price to go up. That’s not too much to ask is it. Bob is playing monopoly with our money trying to build his empire and even himself admitted he doesn’t care what the share price is he will keep spending. By the way Vocare London is still failing having read some notes today. They have spent a small fortune trying to put Vocare right yet still can’t get it to work. Wendy has no idea how to run a profitable business this is not the NHS where she can spend money as and when she wants to try and improve the service Of Vocare. I try and stay positive but when I see the share price continuously drop it’s very difficult. Like I said all I want is to see the share price rise and for the BOD to stop the BS about rewarding investors and get in and do something.
08/7/2019
07:14
1gw: Good that you've got such a rapid response from Wendy, nobby. I can't say the same unfortunately (about my email around the IG interview), but then I don't have a specific email address for her and have to use the public contact details on the tly site. I'm starting to wonder if I need to try elsewhere to get a response. I remain surprised that the nomad would allow Wendy to make the specific statements on valuation she made in an interview apparently aimed at retail investors (given it was with IG and given it looks as though YellowJersey have posted a link to it on the London South East site). In that interview (link also posted here in post 9531 by sikhthetech), as far as I can tell, she makes the comments: "we are ridiculously undervalued"; and "Well, in the latest research notes that have gone out, obviously on the back of the Greenbrook acquisition, they are talking around a share price of around 50p" The second comment in particular is interesting, given the only public target issued post-Greenbrook/dilution that I can find reference to is Allenby's own target which is quoted publicly (by Vox markets) as 20p ("based on our forecasts a fair value of 20p could be attained, a price that would result in a FY2021 PER of 10.4x and a FCF yield of 5.2%."). Of course the other house broker, Canaccord, did apparently use to have a 50p target on tly, but that was before the acquisition and associated dilution. Wendy appears to be suggesting that more than one note ("research notes") has gone out with a 50p target post dilution and she is apparently choosing not to mention the 20p target, dated 20th June, from one of her own house brokers (the same company that happens to be the nomad as well). Now she could be ignoring the house broker note on the basis that house broker notes normally have disclaimers about them being more “marketing” than “independent research” given the relationship between broker and company. But given the house broker target is so far below the 50p being quoted, it might still have been prudent to mention it. Wouldn't you have thought reference to at least one of those 50p target notes might have come into the public domain by now? And if by any chance she misspoke, wouldn’t you have thought the company would have removed the links to the videos or issued some form of acknowledgement by now? -------------------------------------- Sikhthetech 27 Jun '19 - 11:44 - 9531 of 9683 1.000 1 1 Interview https://www.youtube.com/watch?v=fOYSD1vYR_I
20/6/2019
13:42
nobbygnome: Well here goes. I am going to post my report although muppets like 1gw do not deserve any help with their (alleged) investment. This was probably the best company meeting I have ever been to. I was the only investor present and consequently got lots of time to ask questions and speak one to one with directors. Bob Holt was not present but all the other directors were. I am going to do this bullet point style. They were talking to Greenbrook since before the Vocare acquisition. However, it made sense to do Vocare first to get the national presence and then they could add on the London coverage of Greenbrook Wendy insisted that they did not overpay for Vocare. It maybe has taken a bit longer to sort out then they thought but it is now a profitable company. There will be cost savings during the integration due to shared functions. The enlarged group will be able to bid for more contracts than before. For example Greenbrook currently only takes on 2 new contracts a year due to logistical issues. However, now that Greenbrook have the TLY logistics they can take on more new contracts annually. There is not and never has been any cash flow issue on the balance sheet; this has been severely misrepresented by certain people. Yes there are big monthly movements in cash up and down (£3 million or so) which is why they need a big cash balance. The NHS is a very good and predictable payer which facilitates the cash flow. I spoke for a while with Michael Steel from Greenbrook. He is absolutely committed to the new business and sees the takeover as the way to rapidly grow both his business and the wider group. He is there for the long term and is very excited about the opportunities which have opened up. He has been looking to sell the business for a while to accelerate growth and patiently waited for TLY understanding the long term issues. There are multiple cross selling opportunities between the different subsidiaries. In addition, CCGs are often now approaching both Vocare and Greenbrook with contracts rather the other way round. There are very few companies which can actually bid for most of them. Probably the most interesting discussion was about the share buyback. There has been a Heads of Agreement with Greenbrook for a long time. They were waiting for a recovery in the share price to do the the purchase at a higher level, although they eventually had to bite the bullet. Don't forget they have been speaking to them since before the Vocare acquisition. This long term discussion and other issues meant that they were severely limited as to when they could actually do a buyback. In fact there were only 2 days in the whole period when the Nomad would have let them do it. You have to understand that the Vocare and Greenbrook acquisitions were a long term strategy which has been going on for years. Essentially the new enlarged group is now poised for significant growth and profitability About Health is doing very well in retaining and winning new contracts. However, the relative size means they are not always RNSed. The results will be released soon and will meet consensus from the 3 brokers. Vocare is definitely profitable! The enlarged group including the cost savings will clearly be even more profitable (my comment). Various new and existing IIs took part in the placing. Miton bought back in big (£3 million) because their earlier sale had been more of an accounting issue and the fund manager was not in agreement with the decision. Wendy thought that the vast majority of the shares were in sticky hands who would stay for the long term The money from the open offer was not required for the takeover and was just to placate PIs. So the fact that the full amount was not achieved is completely irrelevant as it just increases their cash buffer. I for one am very pleased that they enabled PIs to take part. I also spoke to the head of Vocare. He was very optimistic about the future and saw the acquisition as creating big opportunities. The geographical fit couldn't be better. The political risk is being minimised by some of the contracts being in collaboration with NHS entities. So the NHS entity wins the contract and TLY are just a partner. All the people I spoke to said the political risks were not as big as everyone think, although of course you mustn't ignore them. There is no way that the NHS could take all the urgent and managed care functions back in house. Wendy said there would be no more acquisitions in the foreseeable future. Overall I couldn't be happier about TLY now. As I have said before this is a ridiculously undervalued company. When I suggested to Wendy that the price could triple and no-one could complain, she said 'and the rest'. The company thinks that they are many fold undervalued. I think this is going to become very clear shortly as the turnover, profits and contract wins grow. I can't over emphasise how positive Michael Steel from Greenbrook was. Onwards and upwards.... Of course this is reported on a best endeavours basis and you should DYOR.
07/6/2019
20:42
sikhthetech: 1gw, There's this company who specialise in disinfectant cleaners... you may have heard of them... Byotrol (BYOT).. They bought Medimark, nearly a yr ago as follows..: 1) Initial consideration of £2.3m 2) £0.4m Medimark debt 3) £1.15m cash 4) £1.15m from additional shares @ 4.1p 5) £1.8m deferred subject to achieving EBIDTA targets... Total consideration £4.5m for a company making ADJUSTED EBITDA of ONLY £380k on revenues of just £2.7m... using a similar strategy as TLY.. "year ended 31 March 2018, Medimark reported adjusted EBITDA of GBP380k on revenues of GBP2.7m." "Consideration of up to GBP4.5m is payable in respect of the Acquisition, which includes GBP0.4m of debt that Byotrol is assuming.. Initial consideration of GBP2.3m is payable on completion, being GBP1.15m in cash and GBP1.15m from 28,048,780 new ordinary shares ("Ordinary Shares") being issued at 4.1p per share. An additional GBP1.8m of consideration is payable subject to achieving EBITDA targets in FYE 31 March 2019 and FYE March 2020. The deferred consideration is also to be paid half in cash and half in new ordinary shares." https://uk.advfn.com/stock-market/london/byotrol-BYOT/share-news/Byotrol-PLC-Acquisition-of-Medimark-Scientific-Lim/78126339 The placing price @ 4.1p, the current share price is around 50% lower @ 2.1p. Your ONE post on the acquisition, on the day of acquisition announced: 1gw - 23 Aug 2018 - 13:10:33 - 3152 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT Nice surprise on my return from the beach! Good to see them get the results out today in the end and I like the fact that the acquisition shares are priced above 4p. Also I agree it sounds like good news that the Target trial is being extended - although I suppose it could mean the results are borderline and they need more time to decide whether it is going to be viable. Didn't you look at the accounts, liabilities, strategy etc, before loading up... Oh you did... Management seem to be doing the right thing, eh... Management seem to be doing the right things... 1gw - 28 Feb 2019 - 15:04:42 - 3455 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT I've bought some more. Takes Byotrol into the top 3 in my portfolio. High risk, but management seem to be doing the right things and sound confident. I think there is potential for the share price to do very well, especially if they can derisk the US by landing some licensing deals now that they've got such a good shop window through the Target trial. DON'T YOU THINK BYOT OVERPAID FOR MEDIAMARK???? OR IS IT OK BECAUSE YOU AND YOUR MATES FOOTBALL AND SHRODER ARE ALSO INVESTED IN IT. BYOT MCAP IS HIGHER THAN TLY.
19/5/2019
13:55
1gw: Microscope - do you also believe the earth is flat perhaps? The share price closed at 47p on 23rd October 2017, the day before the Vocare acquisition completed. It was suspended on Friday at 11.25p (according to Yahoo! Finance) Who knows what price placing shares will be issued at? 10p, 8p, less? That is messing up in a big way as far as long-term holders are concerned. It depends how many placing shares they issue, but if it is at the sort of scale that savagedstock has suggested then existing shareholders pretty much lock that loss in because of the dilution. On a willing-seller / willing-buyer basis tly is going to be paying fair value for Greenbrook (plus probably a premium equal to a % of expected synergies). So upside in the merged company comes from exceeding that fair value (plus premium) and any recovery in the underlying existing tly business. Existing tly holders suffer from the dilution (if 2 new placing shares for each 1 existing tly share, then existing holders are exposed to only 1/3 of the upside). And the "reverse" is down to the technical AIM definition - in this case presumably it is the fact that the underlying profit of Greenbrook is higher than that of Tly.
18/5/2019
09:05
1gw: Low risk? What some of our resident rampers were arguing at a share price of around 25p in August 2018 was that Tly was low risk because of the cash on their balance sheet. I was arguing that this was illusory because of the offsetting liabilities on the balance sheet and that if they needed to fix the balance sheet by a further placing they would probably need a good discount on the share price. Fast forward 9 months to today and to me it looks like the last of the cash is likely to disappear buying Greenbrook - on the basis of them having paid around 7 x PBT or 7 x EBITDA up front for PPH and AH, and for Vocare paying up front a bit more than the cash on the Vocare balance sheet. That's assuming the FY19 Greenbrook accounts are similar to the FY18 accounts. So that leaves them having to raise cash to fix the balance sheet and pay any additional amount up front over what is on the Greenbrook balance sheet. Even if they could raise the cash at 10p (and I doubt that) that would represent a 60% loss on the 25p August share price. In what world is that consistent with tly having been a low-risk investment in August? --------------------------------------- sikhthetech - 10 Aug 2018 - 15:35:26 - 4770 of 8791 "Wouldn't you say it was just a little desperate to present Totally's cash balance relative to market cap as somehow indicative of a low risk investment?" No...to me it's low risk...as I've explained/asked.. look at last year's placing and their prior fy2016 accounts… ----------------------------------------- Nobbygnome - 10 Aug 2018 - 11:01:42 - 4738 of 8791 …However, I agree that at this level with the level of cash TLY is very low risk.....despite what some say here. It is all about the management here IMHO...
21/12/2018
10:51
1gw: Stt- away from the conspiracy theories, any thoughts on the share price weakness? Could it be anything to do with the balance sheet and cash consumption, or how the Canaccord note sees it developing? Could it be anything to do with the level of institutional selling since the placing? Could it possibly be partly to do with the failure of the company to follow through on a share buyback despite the share price now being much lower than when they put the authority in place? Could fear of a Corbyn government be a factor? Or do you think it is all because rthm posters are selling tly to distract you from posting over there? ----------------------- sikhthetech - 13 Dec 2018 - 09:12:55 - 10231 of 10391 graham, "Hopefully no one got caught on the spike" Traders, pretending to be holders... Have a look at the small trade on TLY, resulting in share price fall, perfectly timed, so to distract posters from posting here...
06/12/2018
11:40
football: sikhthetech you constantly say the share price or take care of its self once the result out and the market can see the picture looks like the markets seen the complete movie and doesn't like what it's seen, so if you constantly ramping the share and saying the results were excellent wires the share price fallen so much and continues to fall? Could it be concerns over the cash balance like 1gw says that your liabilities are bigger than that or is it that you still have roughly 30% of the authorities still needing attention, maybe the contractual winning are not as good as you say as inflation rises so does wages and your entire business model is based on cheap labour, then again they may be worried that AI technology is taking over the sector and you're just a stopgap to its fully integrated and lastly and ironically it may be that GDPR and data protection are serious concerns here and may lead you open to all sort of litigation, who knows but you've been found lying and 100% wrong saying that the results were excellent and the share price will rise at its done exactly the opposite just hope not too many people got stopped out or bought in on your advice. As you betray the thread as somewhere to listen to bull and bear points about the company but ban anyone that doesn't agree with your gender and only pushes out a ramping point of view and before you say what about your thread it says in my header this is a rampers thread and only positive views so no one can be misled that there only getting one side of the story and should do their research unlike you who say level handed but continually ramp and never allowed negative posts this it's by a blue who you can't stop. I wonder which parts of this post you will edit with your favourite ......... to hide the bits you don't want anyone to see
Totally share price data is direct from the London Stock Exchange
Your Recent History
LSE
TLY
Totally
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191016 23:58:11